Skip to main content

Researchers have received funding to screen and evaluate adjuvants that may improve the ability of coronavirus vaccines to simulate the immune system.

A $20 million engineering research center will help expand the uses of cell-based therapies.

The biosciences are big at Georgia Tech. Researchers discuss what’s happening and how they see the future.